Taken for 1 to 6 months January 30, 2021 For Type 2 Diabetes "Started on Ozempic in September 2020, starting weight 312 lbs (54)
103 Pineda-MolinaE.KlattP.VazquezJ.MarinaA.Garcia De LacobaM.Perez-SalaD.et al (2001)
GLP-1 drugs are not a permanent fix, they manage some symptoms while you take them
In parallel, Eli Lilly developed tirzepatide (Mounjaro)--a dual GLP-1 and GIP receptor agonist
The early stage is characterized by SIRS and organ dysfunction, and although local complications may occur at this stage, they are not major determinants of disease severity
People often notice changes such as hollow cheeks, a more sunken appearance around the eyes, thinner-looking lips, or facial lines that stand out more than they used to